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Extracorporeal shock wave lithotripsy (ESWL) is used safely for management of urinary stones.
The aim of this randomized double blinded study was to compare the effects of dexmedetomi-
dine-ketamine and fentanyl-ketamine combinations on analgesia, sedation, hemodynamics and
respiratory effects in patients underwent ESWL.
Methods: Sixty patients aged between 20 and 50 years, ASA I or II physical status were randomly
assigned into two groups. In Group Fentanyl-ketamine (FK) (n= 27): Patients received fentanyl at
a 1 lg/kg over 10 min before the procedure and 0.5 mg/kg bolus of ketamine. In Group Dexmede-
tomidine-ketamine DK (n= 30): patients received dexmedetomidine 1 lg/kg over 10 min before
the procedure and a 0.5 mg/kg bolus of ketamine. A blinded researcher assessed the patient’s pain
level (primary outcome), sedation level, and awareness via visual analogue scale (VAS), modiﬁed
Observer’s Assessment Alertness/sedation, and bispectral index respectively.
Results: There was a signiﬁcant increase in VAS in the recovery period in FK group. There was a
signiﬁcant decrease in hemodynamics (HR, MAP) in the recovery period in DK group. There was a
signiﬁcant increase in bispectral index values in FK group during the postoperative period. The ﬁrst
36 A.A. El sayed et al.analgesia required was signiﬁcantly longer in DK. There was a signiﬁcant increase in sedation score
in the recovery period in FK group. There was no signiﬁcant difference between the two groups as
regards the adverse effects except nausea and vomiting (signiﬁcant in FK group).
Conclusion: Dexmedetomidine/ketamine combination was accompanied by more prolonged
analgesia in the recovery period, prolonged sedation, and delayed request of ﬁrst dose analgesia
with less nausea and vomiting than fentanyl/ketamine combination.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
Extracorporeal shock wave lithotripsy (ESWL) is used safely
for management of urinary stones. It is a simple, noninvasive
and can be used safely in pediatric patients [1]. The newer gen-
erations of lithotripsy machines are less painful. The anesthetic
agent should achieve adequate analgesia, sedation, immobility
and hemodynamic stability [2]. A relaxed, cooperative patient
is a main key in maintaining stones in place for optimal frag-
mentation. Thus, it is essential to choose a proper combination
of drugs with minimal adverse effects to achieve a proper tar-
get [3].
Anesthetic techniques were changed from general or
regional anesthesia to analgesic sedative techniques [4].
Different analgesic agents including NSAIDS (ketorolac or
diclofenac), opioids (pethedine or morphine) and other anal-
gesic techniques (cutaneous creams or local anesthetic
agents) [5] have been used. NSAIDS are effective for pain
relief with fewer side effects than narcotics; however, it is
associated with hypersensitivity reactions, gastrointestinal
disturbances, and sometimes coagulation disorders [6].
Regional anesthesia like intrathecal sufentanil and lidocaine
can be used. However, these techniques are more time con-
suming to perform with prolonged recovery [7]. The EMLA
cream, an eutectic mixture of prilocaine (2.5%) and ligno-
caine (2.5%) for topical use, has also used in ESWL. How-
ever, it should be used appropriately as an occlusive dressing
for long period (60 min) before the procedure, and in com-
bination with other analgesic agents [8]. Ketamine is one
of the most commonly used drugs to achieve sedation and
analgesia in ESWL. It can be used as a single agent or in
combination with other drugs to achieve deep sedation with
fewer side effects [2]. Dexmedetomidine is highly selective
a2-adrenergic receptor agonist that has sedative analgesic
properties with minimal side effects on ventilation [9]. Being
an agonist for a2-adrenergic receptors, it decreases the
release of catecholamines and it posseses sympatholytic
action which results in bradycardia and hypotension [10].
Because of these effects, dexmedetomidine may be effective
agent for conscious sedation in ESWL [11]. Fentanyl is a
strong synthetic narcotic. But unfortunately it has signiﬁcant
adverse effects like respiratory depression, drowsiness, nau-
sea and vomiting [12].
The aim of this randomized double blinded study was to
compare the effects of dexmedetomidine-ketamine and fenta-
nyl-ketamine combinations on analgesia, sedation, hemody-
namics and respiratory effects (secondary outcome) in
patients underwent ESWL. We hypothesized that dexmede-
tomidine group would provide better analgesia with less side
effects than the fentanyl group.2. Patients and methods
2.1. Patient recruitment
This randomized, double blinded study was done after the
approval of local ethics committee. All patients were
conducted in Dr. Erfan and Bagedo general hospital in
Jeddah-KSA. A written informed consent was obtained from
each patient. Sixty patients aged between 20 and 50 years,
who were scheduled for elective ESWL, were enrolled in our
study. All patients had American Society of Anasthiologist
(ASA) I or II physical status. All patients had a single renal
stone less than or equal 10 mm and ﬁrst time to do ESWL
procedure. Exclusion criteria were allergy to any medications
used in the study, heart block (2nd or 3rd degree), respiratory
disorder or chronic use of drugs known to alter the anesthetic
or analgesic requirements. Also, chronic users of any
a2-agonists were excluded.
2.2. Anesthetic techniques and study protocol
After arrival at the ESWL unit, a 20G IV cannula was inserted
in non dominant hand. All patients were monitored with non-
invasive blood pressure (NIBP), oxygen saturation (SpO2),
ECG, and respiratory rate (RR). A bispectral (BIS) sensor
was attached to the forehead and connected to an Aspect
A2000 monitor version. Then we started an infusion of Ringer
lactate solution at the rate of 80 ml/kg/day in all patients.
Sedation level was evaluated by using the modiﬁed Obser-
ver’s Assessment Alertness/sedation (MOAA/S) scale [13]:
1 = Not responsive to mild shaking (unarousable).
2 = Responsive to mild shaking.
3 = Responsive only to his name when spoken repeatedly
or loudly.
4 = Responsive to the name spoken in normal tone.
5 = Awake and alert.
6 = Agitated.
Pain intensity was evaluated on 0–10 cm visual analog scale
(VAS) [14].
The VAS and MOAA/S were evaluated by another person
who was blinded to all groups.
The patients were divided in a randomized manner into two
groups by a closed envelop method.
Nurses who did not participate in the study prepared all
syringes with dexmedetomidine or fentanyl drugs according
to the table of randomization. The calculated dose of fentanyl
and dexmedetomidine for each patient was prepared in a total
volume of 50 ml normal saline and was infused over a period
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formed in a double-blind fashion in which neither the patient
nor the medical team were aware about the injected drugs.
Three patients in Fentanyl group refused to complete the
study. So those patients were excluded.
In Group Fentanyl-ketamine (FK) (n= 27): Patients
received fentanyl at a 1 lg/kg over 10 min before the procedure
and 0.5 mg/kg bolus of ketamine. In Group Dexmedetomi-
dine-ketamine DK (n= 30): patients received dexmedetomi-
dine 1 lg/kg over 10 min before the procedure and a 0.5 mg/
kg bolus of ketamine. All patients received average 2300
shocks/session at the same power intensity with intensity level
6 and pulse energy (42 mJ), asynchronous using the Dornier
Lithotripter SII, Med Tech, Germany. Additional ketamine
was used when needed (when the patient experienced any pain
or movement) at a dose 0.25 mg/kg in both groups. MOAA/S
score of 3 was accepted to start the procedure. All patients
were supplied by oxygen nasal cannula at rate 4 L/min. When
ESWL completed, the recovery time was assessed with modi-
ﬁed Aldrete score by another anesthetist, who did not partici-
pate in all the procedure. Modiﬁed Aldrete score is a system of
scoring that evaluates the condition of the recovery and dis-
charge of the patient by assessing 5 parameters (oxygenation,
conscious, circulation, respiration, activity). BIS also was
assessed by the same anesthetist. The main outcome for the
recovery period was to achieve a modiﬁed Aldrete score of 9
or more and to achieve BIS 90 or more [15].
2.3. Outcome measures
The primary measure of the study was to assess the VAS score.
The VAS score was recorded at 5 min intervals after the initial
measurement till the end of the procedure, and every 5 min for
15 min in the recovery period.
The secondary measures include hemodynamics, sedation
and analgesia requirement. The basal values for respiratory
rate (RR), mean arterial blood pressure (MAP), heart rate
(HR), MOAA/S and BIS were recorded immediately before
giving the study drug. The MOAA/S score, hemodynamics
(HR, MAP), respiratory rate (RR) and BIS variables were
recorded at 5 min intervals after the initial measurements till
the end of the ESWL procedure. All the previous parameters
were measured again every 5 min for 15 min in the recovery
period.
Other secondary measures included adverse effects like
hypotension (MAP< 50 mmHg), nausea, vomiting and bra-
dycardia (HR< 50/min) were recorded during the procedure.
Normal saline 0.9% infusion at 1–2 ml/kg/h was used for
hypotension till MAP value was 50 mmHg. Atropine
0.01 mg/kg IV was given to treat bradycardia. Ondansetron
4 mg IV was considered for management of nausea and vom-
iting. When upper airway obstruction was noted, jaw thrust
was applied and nasopharyngeal airway was inserted. It was
important for us to keep suction ready for use when excessive
salivation occurred.
2.4. Statistical methods
Data were analyzed using SPSS version 15.0 computer soft-
ware (Chicago, IL, USA). Numerical variables were presented
as mean and standard deviation (SD). Independent T test wasused for inter-group comparisons of numerical variables, while
categorical variables were presented as frequency (%). Chi-
square test was used for comparisons of categorical variables.
P value 60.01 is highly signiﬁcant and P value 60.05 is signif-
icant. Sample size calculation was performed by GPower ver-
sion 3.1.5 computer software [Franz Faul, Universita¨t Kiel,
Germany, 2012]. It revealed that at least 30 patients were
needed in each group for detection of a difference in VAS of
at least 25%, assuming its pooled value is 4 cm (effect
size = 0.7) with a power of 0.85 and signiﬁcance level (a error)
of 0.05 [16].3. Results
During the period of the study, 60 patients with required
ESWL were identiﬁed. Three patients in fentanyl group
refused to complete the study and they were excluded from
the analysis. ASA physical status and the demographic param-
eters of the patients in the two groups were similar. As regards
total operative time, it was comparable. No signiﬁcant differ-
ence between the two groups as regards number of shocks
and total ketamine dosage which was given (Table 1).
There were no statistically signiﬁcant differences between
the 2 groups as regards the RR, MAP and HR preoperatively.
There was reduction in the hemodynamic parameters (HR,
MAP) after 5 min and all over the procedure in both groups,
this reduction was within 15% from the baseline values (not
signiﬁcant), and it was not important clinically. There was a
highly signiﬁcant decrease in HR after 40, 45, 50 min (recovery
period) in DK group in comparison with FK group
(P= 0.005, 0.001, and 0.006 respectively). Also, there was a
signiﬁcant decrease in MAP during recovery period in DK
group in comparison with FK group (P= 0.001, 0.035 and
0.012 respectively). On the other hand, there were no signiﬁ-
cant decreases in RR in the ﬁrst 5 min and all over the proce-
dure in comparison with base line. Also, there was no
signiﬁcant difference between the two groups at the different
time points (Table 2).
As regards BIS values, there was no signiﬁcant difference
between the two groups throughout the procedure while there
was a signiﬁcant increase in FK group during the postopera-
tive period 40, 45 and 50 min) (P= 0.001, 0.02 and 0.01
respectively) (Fig. 1).
As regards VAS values, there was no signiﬁcant difference
between the two groups throughout the procedure while there
was a signiﬁcant increase in FK group during the postopera-
tive period (40, 45 and 50 min) (P= 0.034, 0.045, 0.047 respec-
tively) (Fig. 2).
As regards MOAA/S sedation score values, there was no
signiﬁcant difference between the two groups throughout the
procedure while there was a signiﬁcant increase in sedation
score after 40, 45, 50 min (recovery period) in FK group in
comparison with DK group (P = 0.022, 0.012 and 0.041
respectively) (Fig. 3).
There was no signiﬁcant difference between the two groups
as regards adverse effects like hypotension, hypertension, bra-
dycardia, tachyarrhythmia, or additional ketamine needed.
While there was a signiﬁcant difference between the two groups
regarding nausea and vomiting as 20% (6/30) of patients in DK
group got nausea and vomiting while 51% (14/27) of patients in
FK group developed nausea and vomiting.
Table 1 Demographics, total ketamine used, operative and ESWL data.
DK-group (n= 30) FK-group (n= 27)
Age 40.36 ± 1.44 39.44 ± 4.52
Gender (male/female) 21/9 (70%/30%) 21/6 (77.8%/22.2%)
ASA status (I/II) 21/9 (70%/30%) 19/8 (70.4%/29.6%)
Operative time (min) 34.96 ± 2.39 34.18 ± 2.057
Number of shocks 2300 ± 180.03 2296 ± 275.23
Total ketamine used (mg) 56.3 ± 3.36 56.1 ± 3.35
Data are presented as mean ± SD and ratio for sex and ASA status.
ASA: American Society of Anesthesiology, DK group; Dexmedetomidine-ketamine group, FK group; Fentanyl-ketamine group.
Table 2 Hemodynamics and respiratory rate data.
HR MAP RR
DK-group (n= 30) DK FK DK FK DK FK
FK-group (n= 27) Group Group Group Group Group Group
Baseline 85.5 ± 2.4 85.3 ± 2.8 82.3 ± 2.3 81.7 ± 2.3 21.4 ± 1.3 21.3 ± 1.5
5 min 66.5 ± 1.8 66.9 ± 1.5 74.7 ± 1.9 75.3 ± 1.8 18.4 ± 1.3 18.4 ± 1.3
10 min 64.8 ± 2.6 65.4 ± 2.1 67.2 ± 1.6 67.8 ± 2.1 19.2 ± 1.6 19.4 ± 1.6
15 min 64.03 ± 1.6 63.1 ± 2.6 63.8 ± 1.5 63.1 ± 1.6 19.5 ± 1.8 19.2 ± 2.1
20 min 60.9 ± 2.4 61.6 ± 2.3 59.4 ± 2.5 60.1 ± 2.3 18.6 ± 1.7 19.3 ± 1.6
25 min 61.4 ± 2.1 60.7 ± 1.8 64.9 ± 1.9 65.07 ± 1.7 18.6 ± 1.4 19.3 ± 1.6
30 min 59.7 ± 1.7 59.5 ± 1.8 59.7 ± 2.2 59.4 ± 2.1 19.03 ± 1.1 19.6 ± 1.4
35 min 59.6 ± 1.6 59.4 ± 1.5 65.4 ± 1.6 65.9 ± 1.4 18.2 ± 1.6 18.8 ± 2.7
40 min 64.3 ± 4.2** 67.9 ± 5.1 67.1 ± 2.5** 69.3 ± 2.5 18.6 ± 1.3 19.3 ± 1.4
45 min 72.8 ± 6.02** 78.2 ± 2.9 71.7 ± 7.4* 75.1 ± 2.9 18.7 ± 1.5 19.0 ± 1.6
50 min 82.7 ± 3.9** 85.3 ± 2.7 77.6 ± 3.4* 79.7 ± 2.7 19.1 ± 1.6 19.5 ± 1.6
Data are presented as mean ± SD; HR; heart rate, MAP; mean arterial pressure, RR; respiratory rate, DK group; Dexmedetomidine-ketamine
group, FK group; Fentanyl-ketamine group.
* P< 0.05 = signiﬁcance between groups.
** P< 0.01 = highly signiﬁcance between groups.
Figure 1 Bispectral index (BIS). Group 1; Dexmedetomidine-
ketamine (DK), Group 2; Fentanyl-ketamine (FK). BIS-1, 5, 10,
15, 20, 25, 30, 35, BISPO-1, BISPO-2, BISPO-3; baseline, 5, 10, 15,
20, 25, 30, 35 min intraoperatively, postoperative-1 (40 min),
postoperative-2 (45 min), postoperative-3 (50 min) respectively.
*P< 0.05 = signiﬁcance between groups, **P< 0.01 = highly
signiﬁcance between groups.
Figure 2 VAS; visual analog score. Group 1; Dexmedetomidine-
ketamine (DK), Group 2; Fentanyl-ketamine (FK). VAS 5, 10, 15,
20, 25, 30, 35, PO1, PO2, PO3; 5, 10, 15, 20, 25, 30, 35 min
intraoperatively, postoperative-1 (40 min), postoperative-2
(45 min), postoperative-3 (50 min) respectively. *P< 0.05 = sig-
niﬁcance between groups.
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ESWL is a safe and effective method to treat upper urinary
tract stones, but it causes discomfort and pain in many patients
[17]. Intravenous combination of dexmedetomidine 1 lg/kgover 10 min before the procedure and 0.5 mg/kg bolus of
ketamine as well as same doses of fentanyl - combinations
are effective and tolerated for patients undergoing ESWL.
The dexmedetomidine/ketamine combination is associated
with a more prolonged analgesia in the recovery period
(primary outcome), delayed request of ﬁrst dose analgesia, less
Figure 3 MOAA/S; modiﬁed Observer’s Assessment Alertness/
sedation scale. Group 1; Dexmedetomidine-ketamine (DK),
Group 2; Fentanyl-ketamine (FK). MOAA/S 1, 5, 10, 15, 20,
25, 30, 35, MOAA/S-1, MOAA/S-2, MOAA/S-3; baseline, 5, 10,
15, 20, 25, 30, 35 min intraoperatively, postoperative-1 (40 min),
postoperative-2 (45 min), postoperative-3 (50 min) respectively.
*P< 0.05 = signiﬁcance between groups.
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to fentanyl/ketamine combination.
For the patient satisfaction, the most suitable drug for
ESWL should provide adequate analgesia, sedation, rapid
recovery and minimal side effects [18].
Dexmedetomidine displays speciﬁc and selective a2-adreno-
receptors agonists [19]. Activation of the receptors in the spinal
cord and the brain inhibits ﬁring of the neurons and causing
hypotension, sedation, analgesia and bradycardia [20].
Ketamine is a sedative analgesic agent that does not inter-
fere with the hemodynamics or respiration. It maintains the
airway reﬂexes with better analgesia and sedation [21]. Monk
et al. in his study, compared midazolam-ketamine and midaz-
olam-alfentanil in the lithotripsy and stated that ketamine
infusion provided better respiratory and hemodynamics stabil-
ity. In spite of these beneﬁts, there were prolonged recovery
and emergence delirium when it was used in children [22].
The BIS monitor can be used as an effective and objective tool
to guide the effective and safe doses of anesthetics. There are
several advantages of the BIS as reduction of anesthetic doses,
shorter recovery and early emergence [23].
As regards analgesia in our study, there was a signiﬁcant
difference only in the postoperative period as evident by
increase in VAS score and decreased the mean time to the ﬁrst
required analgesia in FK group than DK group. This signiﬁ-
cant difference might be related to the prolonged analgesic
effect of dexmedetomidine and fading effect of fentanyl. This
ﬁnding is in accordance with the study of Gurbet et al. [24]
who demonstrated that the infusion of dexmedetomidine intra-
operatively decreased perioperative analgesia requirements.
Similar to our ﬁndings, Aho and his colleagues [25] docu-
mented the analgesic properties of dexmedetomidine even
when it was used as a sole agent after minor surgery. Another
study done by Alhashemi and Kaki [26] showed that dexmede-
tomidine was an effective and safe drug to sedate the patients
during ESWL without affection of respiration with better anal-
gesia than propofol. However, our ﬁndings contradict the ﬁnd-
ings of Jalowieck et al. [27] who discussed the ability of
dexmedetomidine to provide analgesia for colonoscopy but
he found that it might induce hemodynamic instability and
prolonged recovery.In our study, there was reduction in the hemodynamic
parameters after 5 min and all over the procedure, this reduc-
tion was within 15% from the baseline values and it was not
signiﬁcant. This none signiﬁcant decrease in hemodynamics
may be explained by the hemodynamic stability of Ketamine.
But there was intergroup signiﬁcant difference during recov-
ery period. It could be again due to prolonged effect of dex-
medetomidine and fading effect of fentanyl and stop of
ketamine. This was in agreement with the results of Feld
and his colleagues [28] who compared the analgesic effects
of dexmedetomidine to fentanyl in bariatric surgery and
reported that dexmedetomidine provided both analgesia and
stable hemodynamics, thus decreased the use of morphine
in the postoperative period. In contrast to our study, Kayg-
usuz et al. [29] stated a signiﬁcant reduction in MAP com-
pared to the baseline when they used fentanyl/propofol for
sedation in ESWL, this is may be related to propofol induced
hypotension.
In the current study, there was no signiﬁcant difference
between the two groups as regards respiratory rate (RR) and
no signiﬁcant difference in comparison with the baseline. This
none signiﬁcant difference might be related to ketamine as it
did not induce clinically important respiratory depression
[21]. The effect of dexmedetomidine on RR is variable. Kayg-
usuz et al. [29] and Belleville et al. [30] stated a signiﬁcant
decrease in RR. While Hsu et al. [31] reported a signiﬁcant
increase in RR with dexmedetomidine. On the other hand,
some authors reported that dexmedetomidine did not affect
RR [32]. These wide changes might be related to variable
methods of administration. Elbert et al. [33] used infusion of
dexmedetomidine similar to Hsu et al. [31] and that study
showed a signiﬁcant increase in RR.
As regards sedation, we were not allowed to start procedure
except when MOAA/S SCORE is 3 and the BIS value was less
than 81. This is in accordance with the study of Yu et al. [34]
who investigated the efﬁcacy of BIS monitoring during bal-
anced propofol sedation for colonoscopy and they found that
the optimal cut-off value of BIS to maintain moderate sedation
was 81. Also, in the study of Yeon, when patients experienced
pain, MOAA/S and BIS were respectively, 3.9 ± 0.7 and
88.5 ± 6.4. While the patients who did not feel pain they were
2.7 ± 0.6 and 77.3 ± 5.1. There is agreement between the
sedation level and BIS value, and many studies have proved
that BIS is an objective method to monitor sedation [35]. In
contrary to our study, Kronen et al. [36] who stated that the
anesthetic period performed by fentanyl was accepted, but
there was prolonged recovery with respiratory and central ner-
vous depression.
One of the drawbacks which cause difference between the
clinical scoring systems of sedation and BIS monitoring is
the BIS timing measurement. When we use the clinical assess-
ment in the form of painful or verbal stimuli, these stimuli lead
to an increase in BIS value. So the BIS timing measurements
change the BIS value [37].
The most common adverse effects of opioids are nausea
and vomiting which reﬂected in our study by a signiﬁcant
increase in the incidence in FK group than DK group (51%
vs. 20% respectively). This could be related to the renal pain,
which was experienced as a result of the operation itself [8], or
related to the effect of fentanyl to induce emesis (nausea and
vomiting) which are the most common side effects of opioids
as observed by Cepeda et al. study [38].
40 A.A. El sayed et al.We had some limitations of our study as it is a single center
study and the sample size required mainly based on the patient
satisfaction which is a subjective tool. The only objective tool
used was the BIS. It was obvious from our study that BIS was
not superior to MOAA/S score in spite of its use may increase
the cost burden. Also, this study was conducted on a speciﬁc
category of patients (young age, ASA I, II and single renal
stone) only.
In conclusion, both dexmedetomidine/ketamine and fenta-
nyl/ketamine combinations at prescribed dose regimen were
effective and tolerated for patients underwent ESWL. How-
ever, dexmedetomidine/ketamine was accompanied by more
prolonged analgesia in the recovery period (primary outcome),
delayed request of ﬁrst dose analgesia with less nausea and
vomiting than and fentanyl/ketamine. The addition of keta-
mine was important factor to keep the hemodynamics and res-
piration are stable. Also there is a good correlation between
MOAA/S sedation score and BIS. Future studies are needed
to compare the other sedation scores and BIS, and to compare
the dexmedetomidine/ketamine with other commonly used
agents during ESWL.Conﬂict of interest
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